NEP INTERLONG (08329) is expected to have a net loss attributable to shareholders of approximately 40 million yuan in the year 2025.
Haiwang International Holdings Limited (08329) announced that it is expected to have a net loss attributable to company owners of approximately RMB 40 million in 2025, while it achieved a net profit of approximately RMB 25 million in 2024.
NEP INTERLONG (08329) announced that the group is expected to incur a net loss of approximately RMB 40 million for the year 2025, while it made a net profit of approximately RMB 25 million in the year 2024.
Related Articles
Shanghai Fosun Pharmaceutical (02196) released its annual performance, with a net profit attributable to the parent company of 3.371 billion yuan, an increase of 21.69% year-on-year.
PER ENERGY (02798) announces annual performance results with a net loss of 1.98 billion yuan, a turnaround from profit to loss on a year-on-year basis.
LIVZON PHARMA (01513) will distribute a final dividend of HK$14.3 per 10 shares.
Shanghai Fosun Pharmaceutical (02196) released its annual performance, with a net profit attributable to the parent company of 3.371 billion yuan, an increase of 21.69% year-on-year.
PER ENERGY (02798) announces annual performance results with a net loss of 1.98 billion yuan, a turnaround from profit to loss on a year-on-year basis.
LIVZON PHARMA (01513) will distribute a final dividend of HK$14.3 per 10 shares.
RECOMMEND
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026
